Dr. Kelly Weselman, Chair of the ACR Ethics Committee, delves into the murky waters of ethical dilemmas in rheumatology. She discusses the balancing act between patient autonomy and medical recommendations, highlighting how tech advancements complicate these issues. The conversation navigates the tough terrain of access to care, treatment costs, and conflicts of interest with pharmaceutical companies. Weselman emphasizes maintaining ethical standards and transparency while addressing the challenges posed by defensive medicine and evolving patient demographics.
